Genmab A/S (GNMSF)
330.37
0.00 (0.00%)
USD |
OTCM |
Jan 20, 16:00
Genmab Price: 330.37 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 60.68 |
| Ascendis Pharma A/S | 215.58 |
| Evaxion AS | 4.68 |
| IO Biotech, Inc. | 0.5156 |
Price Related Metrics
| PE Ratio | 14.06 |
| PS Ratio | 5.796 |
| PEG Ratio | 0.1112 |
| Price to Book Value | 3.539 |
| Price to Free Cash Flow | 17.03 |
| Earnings Yield | 7.11% |
| Market Cap | 20.35B |
| PEGY Ratio | 0.1112 |
| Operating PE Ratio | 15.73 |
| Normalized PE Ratio | 13.99 |